NCT06660251

Brief Summary

The purpose of this clinical trial is to investigate in subjects with and without metabolic syndrome how meals of choline- and carnitine-rich foods (eggs and meat) affect the trimethylamine-N-oxide (TMAO) concentration in blood and urine in relation to the gut microbiota composition. In response to the subjects´ gut microbiota, the concentrations of TMAO in the plasma and urine of subjects with and without metabolic syndrome (MetS) after ingesting choline- and carnitine-rich foods will be compared. On two occasions, participants will receive after overnight fasting meatballs (170 g) or three hard-boiled eggs. Blood will be collected before ingestion and over 6 hours after test food consumption.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
33

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 7, 2020

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 5, 2023

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

May 5, 2024

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

October 7, 2024

Completed
21 days until next milestone

First Posted

Study publicly available on registry

October 28, 2024

Completed
Last Updated

October 28, 2024

Status Verified

October 1, 2024

Enrollment Period

3.2 years

First QC Date

October 7, 2024

Last Update Submit

October 24, 2024

Conditions

Keywords

Metabolic syndromeTMAOGut microbiotaEgg and meatPlasmaUrine

Outcome Measures

Primary Outcomes (2)

  • TMAO and related metabolite concentrations (micromole per litre) in plasma

    TMAO and related metabolites (trimethylamine, betaine, choline, L-carnitine, and acetyl-L-carnitine) were analyzed by UPLC-MRM-MS in plasma samples collected before ingestion of test food and after ingestion at 30, 60, 120, 240, and 360 minutes.

    Metabolite concentrations in plasma samples collected before ingestion of test food and after ingestion at 30, 60, 120, 240, and 360 minutes are used for calculation the incremental area under the curve.

  • TMAO and related metabolite concentrations (micromole per litre) in urine

    TMAO and related metabolites (trimethylamine, betaine, choline, L-carnitine, and acetyl-L-carnitine) were analyzed by UPLC-MRM-MS in a composite urine sample collected during 6 hours post-dose.

    Post-dose sample over a 6-hours period.

Secondary Outcomes (4)

  • Gut microbiota composition

    The day before the first intervention day.

  • Blood glucose and glycated hemoglobin

    At screening (before intervention).

  • Plasma lipid profile

    At screening (before intervention).

  • Body mass index (BMI)

    At screening (before intervention).

Study Arms (2)

Subjects with MetS

ACTIVE COMPARATOR

Subjects with a minimum of three criteria according to NCEP-ATP III. Subjects were administered in randomized order after overnight fasting a test food. Test days were on two separate occasions around 2 weeks apart. Egg intervention: three hard-boiled eggs. Meatball intervention: 170 g meatballs.

Other: Egg interventionOther: Meatball intervention

Subjects without MetS

ACTIVE COMPARATOR

Subjects, apparently healthy, with normal BMI, blood pressure, waist circumference (see inclusion criteria). Subjects were administered in randomized order after overnight fasting a test food. Test days were on two separate occasions around 2 weeks apart. Egg intervention: three hard-boiled eggs. Meatball intervention: 170 g meatballs.

Other: Egg interventionOther: Meatball intervention

Interventions

Oral administration of three hard-boiled eggs to be ingested within 15 minutes on one occasion.

Subjects with MetSSubjects without MetS

Oral intervention with 170 g meatballs to be ingested within 15 minutes on one occasion.

Subjects with MetSSubjects without MetS

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age = 18-75y
  • Plasma creatinine value within the age-related reference range
  • No history of acute or chronic diseases (e.g. diabetes or bowel disease)
  • No use of vitamin or mineral supplements, no medication with antibiotics 2 months before recruitment and during the study
  • Non-smoker
  • Not consuming a special diet (vegetarian)
  • No pregnancy, planned conception, or lactation
  • No participation in another study.
  • Normal BMI (18.6 to 29.0 kg / m 2 )
  • Blood counts within reference ranges
  • Normal ranges for liver enzymes (P-ALAT, P-AST, P-ALP), blood status, plasma triglycerides, plasma HDL cholesterol, plasma cholesterol, plasma glucose
  • A minimum of three of the following criteria according the National Cholesterol Education Program Adult Treatment Panel (NCEP-ATP III):
  • Waist size \> 102 cm in men, \> 88 cm in women
  • Fasting plasma glucose ≥ 5.6 mmol /l
  • Triglycerides \> 1.7 mmol / l or treatment
  • +2 more criteria

You may not qualify if:

  • Smoker
  • Pregnancy, planned conception, or lactation
  • Medical treatment with antibiotics 2 months before recruitment and during the study
  • Use of dietary supplements 2 weeks before and during the study
  • Use of probiotics 2 months before and during the study
  • Following a special diet (eg vegan, vegetarian, weight loss)
  • Participation in another study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Health and Life Sciences, Linnaeus University

Kalmar, 392 31, Sweden

Location

MeSH Terms

Conditions

Metabolic Syndrome

Condition Hierarchy (Ancestors)

Insulin ResistanceHyperinsulinismGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Study Officials

  • Mohammed E Hefni, Assoc Prof

    Linnaeus University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Model Details: A randomized, crossover intervention with two active groups (subjects with and without MetS) using two test foods (egg and meat, with high content of TMAO precursors) was carried out.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assoc Prof

Study Record Dates

First Submitted

October 7, 2024

First Posted

October 28, 2024

Study Start

February 7, 2020

Primary Completion

May 5, 2023

Study Completion

May 5, 2024

Last Updated

October 28, 2024

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will not share

There is no plan to share individual data as all data will be presented in the main article through tables and figures or in the supplementary material as mean ± standard deviation. However, individual data will be made available upon reasonable request.

Locations